It’s Not A Fantasy To Think That Jaguar Health Inc (JAGX) Has Big Future Potential

Jaguar Health Inc (NASDAQ:JAGX) currently has a daily average trading volume of 61.45M but it saw 19430736 shares traded in last market. With a market cap of 46.96M USD, the company’s current market price of $0.17 came rising about 0.06 while comparing to the previous closing price of $0.17. In past 52 weeks, the stock remained buoying in the range of price level as high as $1.22 and as low as $0.05.

Taking a look at 20-day trading activity of Jaguar Health Inc (JAGX) gives us an average price of $0.1223, while its current price level is -86.07% below from 52-week high level whereas it is 232.03% above from lowest level seen by the stock during that period. Simple moving average of 50 days or SMA-50 of the stock’s closing price is $0.0945 while that of 200 days or SMA-200 reads an average of $0.2589. A closer look into the stock’s movement over the week reveals that its volatility is standing at 16.94% during that period while stretching the period over a month that increases to 22.95%. It is also necessary to take a look into other indicators of a stock too, to get a better idea about its price movement. And in doing so, we find stock’s 14-day relative strength index (RSI) standing at 63.99 which implies that the stock is in neutral territory.

The company’s shares got several price updates from the analyst firms in past one month and most recent of them is from the Cantor Fitzgerald which initiated the stock as “Overweight” in its note to investors issued on July 07, 2021, recommending a price target of $5 for it.

Over the week, JAGX’s stock price is moving -4.01% down while it is 146.38% when we observe its performance for the past one month. Year-to-date it is 12.29% up and over the past year, the stock is showing a downside performance of -64.36%.

Currently, Jaguar Health Inc’s total number of outstanding shares is 276.22M. Company’s return on investment (ROI) stands at -112.11% and return on equity (ROE) at -1919.14%. Stock’s beta reads 1.10. Stock has a price to book (P/B) ratio of 2.51 while price to sale or P/S ratio amounts to 4.81. Its return on asset (ROA) is -84.10% on average.